← Association for Accessible Medicines
FDANonrulemakingFDA-2023-D-5016

Protocol Deviations for Clinical Investigations of Drugs, Biological Products, and Devices; Draft Guidance for Industry; Availability

RIN
—
Last modified
Oct 29, 2025
Comment window
closed 515d ago
Association for Accessible Medicines filings
1

Activity

Association for Accessible Medicines filed 1 comment on this docket between Feb 28, 2025 and Feb 28, 2025. 1 other organizations filed here. The comment window closed 515d ago.

What Association for Accessible Medicines filed (1)

Feb 28, 2025· Comment from Association for Accessible Medicines (AAM)· FDA-2023-D-5016-0039

FDA, Please find attached comments from the Association for Accessible Medicines (AAM) regarding Docket No. FDA-2023-D-5016 "Protocol Deviations for Clinical Investigations of Drugs, Biological Products, and Devices; Draft Guidance for Industry" Thanks, Scott Kuzner, Ph.D., Senior Director, Sciences and Regulatory Affairs, AAM

View on regulations.gov →

Abstract

OPEN

View on regulations.gov →

Co-filers (1)

See everyone who commented →